Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leon Aarons

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
The Journal of Pharmacy and Pharmacology|June 28, 2017
Choosing an optimal input for an intravenous glucose tolerance test to aid parameter identificationEmma C Martin, James W T Yates, Kayode Ogungbenro, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 8, 2023
Investigation of simplified physiologically-based pharmacokinetic models in rat and humanEstelle Yau, Andrés Olivares-Morales, Kayode Ogungbenro, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 27, 2015
Incorporation of stochastic variability in mechanistic population pharmacokinetic models: handling the physiological constraints using normal transformationsNikolaos Tsamandouras, Thierry Wendling, Amin Rostami-Hodjegan, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 9, 2009
Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial resultsMarylore Chenel, François Bouzom, Fanny Cazade, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 21, 2012
Structural identifiability analysis and reparameterisation (parameter reduction) of a cardiovascular feedback modelS Y Amy Cheung, Oneeb Majid, James W T Yates, et al.
Cancer Chemotherapy and Pharmacology|March 27, 2004
Population pharmacokinetic model for daunorubicin and daunorubicinol coadministered with zosuquidar.3HCl (LY335979)Sophie Callies, Dinesh P de Alwis, Atul Mehta, et al.
Pharmacogenetics and Genomics|October 28, 2016
Modelling of atorvastatin pharmacokinetics and the identification of the effect of a BCRP polymorphism in the Japanese populationNikolaos Tsamandouras, Yingying Guo, Thierry Wendling, et al.
The Journal of Pharmacy and Pharmacology|February 8, 2012
Comparison of in-vivo and in-silico methods used for prediction of tissue: plasma partition coefficients in ratHelen Graham, Mike Walker, Owen Jones, et al.
Pharmaceutical Research|October 16, 2010
A semi-mechanistic gastric emptying model for the population pharmacokinetic analysis of orally administered acetaminophen in critically ill patientsKayode Ogungbenro, Lakshmi Vasist, Robert Maclaren, et al.
British Journal of Clinical Pharmacology|October 22, 2009
Population pharmacokinetics and optimal design of paediatric studies for famciclovirKayode Ogungbenro, Ivan Matthews, Michael Looby, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
The Journal of Pharmacy and Pharmacology|June 28, 2017
Choosing an optimal input for an intravenous glucose tolerance test to aid parameter identificationEmma C Martin, James W T Yates, Kayode Ogungbenro, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 8, 2023
Investigation of simplified physiologically-based pharmacokinetic models in rat and humanEstelle Yau, Andrés Olivares-Morales, Kayode Ogungbenro, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 27, 2015
Incorporation of stochastic variability in mechanistic population pharmacokinetic models: handling the physiological constraints using normal transformationsNikolaos Tsamandouras, Thierry Wendling, Amin Rostami-Hodjegan, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 9, 2009
Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial resultsMarylore Chenel, François Bouzom, Fanny Cazade, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 21, 2012
Structural identifiability analysis and reparameterisation (parameter reduction) of a cardiovascular feedback modelS Y Amy Cheung, Oneeb Majid, James W T Yates, et al.
Cancer Chemotherapy and Pharmacology|March 27, 2004
Population pharmacokinetic model for daunorubicin and daunorubicinol coadministered with zosuquidar.3HCl (LY335979)Sophie Callies, Dinesh P de Alwis, Atul Mehta, et al.
Pharmacogenetics and Genomics|October 28, 2016
Modelling of atorvastatin pharmacokinetics and the identification of the effect of a BCRP polymorphism in the Japanese populationNikolaos Tsamandouras, Yingying Guo, Thierry Wendling, et al.
The Journal of Pharmacy and Pharmacology|February 8, 2012
Comparison of in-vivo and in-silico methods used for prediction of tissue: plasma partition coefficients in ratHelen Graham, Mike Walker, Owen Jones, et al.
Pharmaceutical Research|October 16, 2010
A semi-mechanistic gastric emptying model for the population pharmacokinetic analysis of orally administered acetaminophen in critically ill patientsKayode Ogungbenro, Lakshmi Vasist, Robert Maclaren, et al.
British Journal of Clinical Pharmacology|October 22, 2009
Population pharmacokinetics and optimal design of paediatric studies for famciclovirKayode Ogungbenro, Ivan Matthews, Michael Looby, et al.
Pageof 13